WebApr 13, 2024 · 6.50% of CytomX Therapeutics stock is owned by insiders. Which CytomX Therapeutics insiders have been selling company stock? The following insiders have sold CTMX shares in the last 24 months: Amy C Peterson ($10,597.46), Carlos Campoy ($5,607.58), Jeffrey B Landau ($5,972.52), Lloyd A Rowland ($7,954.84), and Sean A … WebApr 10, 2024 · CytomX Therapeutics finds support from accumulated volume at $1.79 and this level may hold a buying opportunity as an upwards reaction can be expected when …
CTMX CytomX Therapeutics, Inc. - SeekingAlpha
WebJul 6, 2024 · SOUTH SAN FRANCISCO, Calif., July 06, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated oncology therapeutics, today announced ... WebJan 19, 2024 · SOUTH SAN FRANCISCO, Calif., Jan. 19, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX ), a clinical-stage, oncology-focused biopharmaceutical company with a vision of... how many body parts does a human have
CytomX Therapeutics Inc. (CTMX) Shares Up Despite Recent …
WebDec 24, 2024 · Hedge funds were also right about betting on CTMX as the stock returned 18.8% since the end of Q3 (through 12/14) and outperformed the market. Hedge funds were rewarded for their relative bullishness. WebJan 20, 2024 · CytomX Therapeutics, Inc. CTMX announced that the FDA has approved its investigational new drug application for commencing a clinical study that will evaluate CX-904 for the treatment of advanced... WebMar 2, 2024 · CTMX Competitors. News Profile Analyst Coverage 5 Yr. Financials Dividends Adv. Charts Earnings Options Price History Events Insiders. CytomX Therapeutics Inc. … high pressure gasket sealer